# John Marshall Bancorp, Inc.: financial statements, quarterly

JMSB · Nasdaq · CIK 1710482 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/jmsb.md) · [Financials](/companies/jmsb/financials.md) · [Filings](/companies/jmsb/filings.md) · [Insiders](/companies/jmsb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/jmsb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001104659-26-092388.md) | not reported | not reported | not reported | not reported |
| Interest expense | $m | [14.3](/filings/0001558370-23-018129.md) | [14.6 d](/filings/0001558370-24-003634.md) | [15.2](/filings/0001558370-24-008074.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(1.5)](/filings/0001558370-24-015445.md) | [1.4 d](/filings/0001558370-25-003982.md) | [1.2](/filings/0001558370-25-007505.md) | [1.1](/filings/0001558370-25-011157.md) | [1.1](/filings/0001104659-25-112012.md) | [1.3 d](/filings/0001104659-26-027378.md) | [1.4](/filings/0001104659-26-057594.md) | [1.5](/filings/0001104659-26-092388.md) | [1.5](/filings/0001104659-25-112012.md) | [1.8 d](/filings/0001104659-26-027378.md) | [1.7](/filings/0001104659-26-057594.md) | [2.0](/filings/0001104659-26-092388.md) |
| Net income | $m | [(10.1)](/filings/0001558370-24-015445.md) | [4.5 d](/filings/0001558370-25-003982.md) | [4.2](/filings/0001558370-25-007505.md) | [3.9](/filings/0001558370-25-011157.md) | [4.2](/filings/0001104659-25-112012.md) | [4.8 d](/filings/0001104659-26-027378.md) | [4.8](/filings/0001104659-26-057594.md) | [5.1](/filings/0001104659-26-092388.md) | [5.4](/filings/0001104659-25-112012.md) | [5.9 d](/filings/0001104659-26-027378.md) | [6.1](/filings/0001104659-26-057594.md) | [7.0](/filings/0001104659-26-092388.md) |
| Diluted EPS | $ per share | [(0.72)](/filings/0001558370-24-015445.md) | not reported | [0.30](/filings/0001558370-25-007505.md) | [0.27](/filings/0001558370-25-011157.md) | [0.30](/filings/0001104659-25-112012.md) | not reported | [0.34](/filings/0001104659-26-057594.md) | [0.36](/filings/0001104659-26-092388.md) | [0.38](/filings/0001104659-25-112012.md) | not reported | [0.43](/filings/0001104659-26-057594.md) | [0.50](/filings/0001104659-26-092388.md) |
| Basic EPS | $ per share | [(0.72)](/filings/0001558370-24-015445.md) | not reported | [0.30](/filings/0001558370-25-007505.md) | [0.27](/filings/0001558370-25-011157.md) | [0.30](/filings/0001104659-25-112012.md) | not reported | [0.34](/filings/0001104659-26-057594.md) | [0.36](/filings/0001104659-26-092388.md) | [0.38](/filings/0001104659-25-112012.md) | not reported | [0.43](/filings/0001104659-26-057594.md) | [0.50](/filings/0001104659-26-092388.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [193](/filings/0001558370-23-018129.md) | [99.0](/filings/0001558370-25-003982.md) | [153](/filings/0001558370-24-008074.md) | [183](/filings/0001558370-24-011986.md) | [177](/filings/0001558370-24-015445.md) | [122](/filings/0001104659-26-027378.md) | [169](/filings/0001558370-25-007505.md) | [117](/filings/0001558370-25-011157.md) | [164](/filings/0001104659-25-112012.md) | [130](/filings/0001104659-26-092388.md) | [150](/filings/0001104659-26-057594.md) | [159](/filings/0001104659-26-092388.md) |
| Total assets | $m | [2,298](/filings/0001558370-23-018129.md) | [2,243](/filings/0001558370-25-003982.md) | [2,252](/filings/0001558370-24-008074.md) | [2,270](/filings/0001558370-24-011986.md) | [2,274](/filings/0001558370-24-015445.md) | [2,235](/filings/0001104659-26-027378.md) | [2,272](/filings/0001558370-25-007505.md) | [2,268](/filings/0001558370-25-011157.md) | [2,325](/filings/0001104659-25-112012.md) | [2,333](/filings/0001104659-26-092388.md) | [2,352](/filings/0001104659-26-057594.md) | [2,402](/filings/0001104659-26-092388.md) |
| Total liabilities | $m | [2,078](/filings/0001558370-23-018129.md) | [2,013](/filings/0001558370-25-003982.md) | [2,017](/filings/0001558370-24-008074.md) | [2,034](/filings/0001558370-24-011986.md) | [2,031](/filings/0001558370-24-015445.md) | [1,988](/filings/0001104659-26-027378.md) | [2,019](/filings/0001558370-25-007505.md) | [2,014](/filings/0001558370-25-011157.md) | [2,065](/filings/0001104659-25-112012.md) | [2,067](/filings/0001104659-26-092388.md) | [2,084](/filings/0001104659-26-057594.md) | [2,129](/filings/0001104659-26-092388.md) |
| Long-term debt | $m | [24.7](/filings/0001558370-23-018129.md) | [24.7](/filings/0001558370-25-003982.md) | [24.7](/filings/0001558370-24-008074.md) | [24.7](/filings/0001558370-24-011986.md) | [80.8](/filings/0001558370-24-015445.md) | [80.8](/filings/0001104659-26-027378.md) | [80.8](/filings/0001558370-25-007505.md) | [80.8](/filings/0001558370-25-011157.md) | [80.9](/filings/0001104659-25-112012.md) | [80.9](/filings/0001104659-26-092388.md) | [80.9](/filings/0001104659-26-057594.md) | [80.9](/filings/0001104659-26-092388.md) |
| Short-term borrowings | $m | [54.0](/filings/0001558370-23-018129.md) | [54.0](/filings/0001558370-25-003982.md) | [77.0](/filings/0001558370-24-008074.md) | [77.0](/filings/0001558370-24-011986.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [221](/filings/0001558370-24-015445.md) | [230](/filings/0001104659-26-027378.md) | [235](/filings/0001558370-25-011157.md) | [235](/filings/0001104659-25-112012.md) | [243](/filings/0001104659-25-112012.md) | [247](/filings/0001104659-26-092388.md) | [253](/filings/0001104659-26-092388.md) | [254](/filings/0001104659-26-092388.md) | [260](/filings/0001104659-25-112012.md) | [266](/filings/0001104659-26-092388.md) | [268](/filings/0001104659-26-092388.md) | [274](/filings/0001104659-26-092388.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2.1 d](/filings/0001558370-24-015445.md) | [5.4 d](/filings/0001558370-25-003982.md) | [0.2](/filings/0001558370-25-007505.md) | [10.2 d](/filings/0001558370-25-011157.md) | [1.4 d](/filings/0001104659-25-112012.md) | [5.5 d](/filings/0001104659-26-027378.md) | [7.0](/filings/0001104659-26-057594.md) | [7.5 d](/filings/0001104659-26-092388.md) | [1.2 d](/filings/0001104659-25-112012.md) | [6.9 d](/filings/0001104659-26-027378.md) | [8.5](/filings/0001104659-26-057594.md) | [5.0 d](/filings/0001104659-26-092388.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001558370-24-015445.md) | [0.1 d](/filings/0001558370-25-003982.md) | [0.1](/filings/0001558370-25-007505.md) | [0.1 d](/filings/0001558370-25-011157.md) | [0.1 d](/filings/0001104659-25-112012.md) | [0.3 d](/filings/0001104659-26-027378.md) | [0.3](/filings/0001104659-26-057594.md) | [0.2 d](/filings/0001104659-26-092388.md) | [0.0 d](/filings/0001104659-25-112012.md) | [0.0 d](/filings/0001104659-26-027378.md) | [0.0](/filings/0001104659-26-057594.md) | [0.0 d](/filings/0001104659-26-092388.md) |
| Dividends paid | $m | [0.0 d](/filings/0001558370-24-015445.md) | [0.0 d](/filings/0001558370-25-003982.md) | not reported | not reported | [0.0 d](/filings/0001104659-25-112012.md) | [0.0 d](/filings/0001104659-26-027378.md) | not reported | not reported | [0.0 d](/filings/0001104659-25-112012.md) | [0.0 d](/filings/0001104659-26-027378.md) | [1.3](/filings/0001104659-26-057594.md) | [1.3 d](/filings/0001104659-26-092388.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [(0.0) d](/filings/0001104659-25-112012.md) | [0.0 d](/filings/0001104659-26-027378.md) | [0.0](/filings/0001104659-26-057594.md) | [1.3 d](/filings/0001104659-26-092388.md) | [0.3 d](/filings/0001104659-25-112012.md) | [0.8 d](/filings/0001104659-26-027378.md) | [2.0](/filings/0001104659-26-057594.md) | [0.0 d](/filings/0001104659-26-092388.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [14.1](/filings/0001558370-23-018129.md) | [14.2](/filings/0001558370-24-008074.md) | [14.1](/filings/0001558370-24-011986.md) | [14.1](/filings/0001558370-24-015445.md) | [14.2](/filings/0001558370-25-007505.md) | [14.2](/filings/0001558370-25-011157.md) | [14.2](/filings/0001104659-25-112012.md) | [14.2](/filings/0001104659-26-057594.md) | [14.2](/filings/0001104659-26-092388.md) | [14.2](/filings/0001104659-25-112012.md) | [14.1](/filings/0001104659-26-057594.md) | [14.0](/filings/0001104659-26-092388.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 14,112,134 at 2026-07-30, from the cover of the [10-Q filed 2026-08-07](/filings/0001104659-26-092388.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.